One of the most common reasons medical devices from non-EU manufacturers get stopped at EU customs is incorrect or incomplete labelling. It is also one of the most avoidable problems. EU MDR has very specific labelling requirements — and getting them wrong does not just delay your shipment, it can result in the entire batch being rejected or recalled.
This guide covers everything your label must include to comply with EU MDR 2017/745, the language requirements, UDI labelling obligations, and the mistakes that most commonly catch non-EU manufacturers by surprise.
Many non-EU manufacturers assume that if their product is labelled correctly for the US FDA or another market, the EU label is similar enough. It is not. EU MDR has its own specific mandatory elements, its own symbology requirements, and critically — it requires your EU Authorized Representative's name and address on every label. This single missing element is responsible for a significant proportion of EU customs rejections of medical devices from non-EU countries.
EU MDR Annex I, Chapter III specifies the information that must appear on the label of every medical device placed on the EU market. All of the following are mandatory:
EU MDR requires that labelling information is provided in the official language of the member state where the device is sold. If you are selling across multiple EU countries, your label must include all required languages for those markets — or you must use separate country-specific labels.
Standardised symbols from ISO 15223 can replace text on the label where the symbol is universally understood, but any text that remains on the label must be in the local language. For most non-EU manufacturers selling EU-wide, this means either a multilingual label or a modular packaging system with language-specific inserts.
The Unique Device Identifier (UDI) system is one of the most significant labelling changes introduced by EU MDR. Every medical device placed on the EU market must carry a UDI carrier on the label — a barcode, QR code, or RFID tag that encodes the device identifier.
The UDI system has two components:
The UDI-DI must be registered in EUDAMED before the device can be placed on the market. Your EU Authorized Representative handles this registration on your behalf.
The EC REP symbol followed by your EU Authorized Representative's full name, company name, and address must appear on every label. This is not optional and it is not acceptable to include it only in the Instructions for Use. It must be on the device label or primary packaging itself.
For NordMDR AB clients, your label would show:
As your EU Authorized Representative, NordMDR AB provides your EC REP details for your label, reviews your labelling against EU MDR Annex I requirements, confirms your UDI carrier format, and checks your language compliance before your first shipment reaches Europe. This labelling review is included as part of our EU AR service — not an additional charge.
NordMDR AB provides EU Authorized Representative services including labelling review for manufacturers from anywhere outside the EU. Stockholm-based. Fixed fees. 5-day onboarding.
Get Free Labelling Assessment →